2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$15.96+$0.04 (+0.22%)
Price as of Oct 22, 2026 7:56 PM EDT- $1.6BMarket Cap
- -51.96%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$15.96+$0.04 (+0.22%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.92 | ||
Change | -$0.10 (-0.62%) | ||
Open | $16.02 | ||
High | $16.31 | ||
Low | $15.79 | ||
Previous Close | $16.02 | ||
Volume | 2,825,639 | ||
30-Day Average Volume | 4,260,051 | ||
1-Week Change | 6.85% | ||
1-Month Change | 8.67% | ||
1-Year Change | -51.96% | ||
3-Year Change | -51.93% | ||
5-Year Change | -79.69% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $1.3B | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $112.0M | ||
Net Income | -$92.0M | ||
Free Cash Flow | -$98.0M | ||
EBIT | -$91.0M | ||
EBITDA | -$83.0M | ||
Net Working Capital | $255.0M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -5 | ||
P/E | -18 | ||
PEG | -0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue